#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2654	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2264	344.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1785	1785	T	375	T	311	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2654	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2264	344.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1519	1519	C	396	C	317	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2654	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2264	344.4	0	HET	.	.	.	A69G	.	69	69	A	404	404	A	403	A,G	256,81	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4134	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3912	316.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1843	1843	A	326	A,G,C	267,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4134	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3912	316.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2477	2477	C	413	C	334	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4134	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3912	316.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2551	2551	A	445	A,C	357,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4134	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3912	316.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3103	3103	C	363	C,A	293,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4134	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3912	316.5	0	HET	.	.	.	C2626CGGGGG,CGGGG	.	2626	2626	C	3132	3132	C	351	CGGGGG,CGGGG	168,102	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	300	folP	852	852	99.88	folP.l15.c30.ctg.1	1730	51.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	864	866	AAA	71;71;72	A;A,C;A	61;61,1;59	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	300	folP	852	852	99.88	folP.l15.c30.ctg.1	1730	51.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1095	1097	AGC	65;66;66	A;G,A;C	55;53,1;52	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	738	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3669	60.2	1	SNP	p	S91F	0	.	.	271	273	TCC	702	704	TCC	56;56;56	T;C;C	43;45;47	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	738	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3669	60.2	1	SNP	p	D95G	0	.	.	283	285	GAC	714	716	GAC	56;56;56	G;A,C;C	46;45,1;47	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	738	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3669	60.2	1	SNP	p	D95N	0	.	.	283	285	GAC	714	716	GAC	56;56;56	G;A,C;C	46;45,1;47	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	342	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1817	56.4	1	SNP	p	G45D	0	.	.	133	135	GGC	710	712	GGC	94;93;93	G;G;C	74;76;72	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	172	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1246	40.8	0	.	n	.	0	A197.	DEL	197	197	A	742	742	A	69	A	61	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	860	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3159	81.3	1	SNP	p	D86N	0	.	.	256	258	GAC	694	696	GAC	98;98;98	G;A;C	78;81;81	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	860	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3159	81.3	1	SNP	p	S87R	0	.	.	259	261	AGT	697	699	AGT	98;98;98	A;G;T	77;82;80	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	860	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3159	81.3	1	SNP	p	S87I	0	.	.	259	261	AGT	697	699	AGT	98;98;98	A;G;T	77;82;80	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	860	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3159	81.3	1	SNP	p	S87W	0	.	.	259	261	AGT	697	699	AGT	98;98;98	A;G;T	77;82;80	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	860	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3159	81.3	1	SNP	p	S88P	0	.	.	262	264	TCC	700	702	TCC	98;97;96	T;C;C,T	78;80;79,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	700	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2971	70.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1729	1731	GGC	99;100;100	G,T;G,A;C,G	79,1;79,1;81,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1330	1332	GCA	77;75;76	G;C;A	59;62;59	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1333	1335	ATC	77;77;77	A;T;C	62;61;64	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1345	1347	GTG	73;73;74	G;T;G	54;56;59	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1345	1347	GTG	73;73;74	G;T;G	54;56;59	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1849	1851	ACC	62;62;63	A;C;C	54;52;55	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1903	1905	GCG	65;65;65	G;C;G	55;50;53	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1903	1905	GCG	65;65;65	G;C;G	55;50;53	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2026	2028	GGC	71;71;72	G,C;G;C	53,1;56;55	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2035	2037	GGC	74;75;75	G,C;G;C	52,1;56;59	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	576	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2629	65.3	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2053	2055	CTG	75;75;75	C;T;G	60;58;55	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	936	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3457	81.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1800	1802	CCG	74;73;73	C;C;G	56;61;58	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	434	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2172	59.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	749	749	C	68	C	58	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	512	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2170	70.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	641	643	GAA	118;118;118	G;A;A	94;97;95	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	512	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2170	70.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	929	931	GAT	111;110;111	G;A,G;T	93;87,1;90	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	512	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2170	70.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1052	1054	TCA	109;109;110	T;C;A	82;84;84	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	512	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2170	70.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1181	1183	GTC	95;94;94	G;T;C	73;74;78	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	512	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2170	70.7	1	SNP	p	G120K	1	.	.	358	360	AAG	887	889	AAG	114;114;114	A;A;G	91;91;90	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	512	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2170	70.7	1	SNP	p	A121D	1	.	.	361	363	GAC	890	892	GAC	115;116;116	G;A;C	93;93;92	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	512	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2170	70.7	1	SNP	p	D121N	0	.	.	361	363	GAC	890	892	GAC	115;116;116	G;A;C	93;93;92	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1778	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5111	104.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2088	2090	AAT	81;81;81	A;A;T,G	68;69;68,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	270	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1425	56.6	1	SNP	p	V57M	1	.	.	169	171	ATG	782	784	ATG	102;102;103	A;T,G;G	81;85,1;83	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
